NCT06549088
Analysis of Lung Cancer Tissue With Spatial Frequency Domain Imaging
Enrolling by Invitation
Not specifiedAges 18+ObservationalUniversity of California, IrvineInvestigator-initiated
~20 participants
Updated 2024-08-12 on ClinicalTrials.gov
What's tested:Spatial Frequency Domain Imaging
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Markers of native lung parenchyma
Measured over May 7, 2023 to December 31, 2026
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Greater than or equal to 18 years old
Suspected or confirmed lung nodule on diagnostic imaging
Undergoing lung resection using an open, endoscopic, or robotic approach
Standard of care orders placed for a pathology assessment of resected lung tissue
Adults undergoing lung resection for a lung mass
Exclusion
\<18 years old
Pregnant females and incarcerated individuals
No standard of care orders to obtain a pathology assessment
RUSH pathology order for resected lung tissue
Any condition where the principal investigator determines to impact patient safety or quality of care
What this trial measures
- Markers of native lung parenchymaMay 7, 2023 to December 31, 2026
Use SFDI to identify markers of lung nodule vs native lung parenchyma